Christopher S Shackelton

CIK 1430708 · last filed 2026-06-10

Christopher S Shackelton is a corporate insider who has filed 70 SEC Form 4 insider transactions across 15 companies since 2012. The most recent filing shows the insider sold $621.0M of UTI on Jun 10, 2026. Across all open-market trades the lifetime net is −$1.32B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $306.6M across reported positions. 321 SEC filings were submitted jointly with Coliseum Capital Management, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.57M

Companies

15

Total Filings

70

Lifetime Open-Market Net

-$1.32B

Filer Profile

Reported Address
105 ROWAYTON AVENUE
ROWAYTON, CT 06853
Related Filers
Coliseum Capital Management, LLC — 321 joint filings, latest 2026-06-10
COLISEUM CAPITAL PARTNERS, L.P. — 308 joint filings, latest 2026-06-10
Coliseum Capital, LLC — 308 joint filings, latest 2026-06-10
Adam Gray — 308 joint filings, latest 2026-06-10
Coliseum Capital Partners II, L.P. — 160 joint filings, latest 2025-01-14
Coliseum Capital Co-Invest III, L.P. — 41 joint filings, latest 2025-07-16
Coliseum Capital Co-Invest, L.P. — 37 joint filings, latest 2020-11-12
BLACKWELL PARTNERS LLC - SERIES A — 17 joint filings, latest 2015-01-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UTI Director 971,440 $20.31 $19.73M -$1.09B 8 2026-06-10
SONO 10%+ Owner 14,505,191 $15.12 $219.32M $74.02M 1 2025-07-29
ACCENDRA HEALTH INC/VA/ (OMI) Delisted 10%+ Owner 9,824,599 $2.80 $27.52M $136.93M 1 2025-03-04
ModivCare Inc (MODV) Delisted Director 4,155,129 $0.44 $1.83M -$140.05M 5 2025-01-14
MCFT 10%+ Owner 3,334,208 $19.64 $65.48M $26.40M 2 2024-06-25
Lazydays Holdings, Inc. (LAZY) Delisted Director 6,190,050 $5.34 $33.05M $259.97M 9 2024-05-17
BLBD Director 0 $61.84 $0 -$315.79M 5 2023-09-18
GMS Inc. (GMS) Delisted 10%+ Owner 6,135,360 $109.96 $674.64M -$140.59M 1 2023-06-14
PRPL Director 621,789 $3.27 $2.03M $0 1 2021-03-09
ModivCare Inc (PRSC) Delisted Director 869,091 -$59.07M 5 2020-03-05
Option Care Health, Inc. (BIOS) Delisted Director 1,888,991 $10.79 $20.39M $6.85M 2 2019-07-10
Purple Innovation, Inc. (PRPLW) Delisted Director $0 1 2019-02-28
LHC Group, Inc (LHCG) Delisted Director 784,394 $169.81 $133.20M -$86.93M 12 2017-03-03
ACCURIDE CORP (ACW) Delisted 10%+ Owner 8,539,764 $4.74M 1 2016-05-05
Arq, Inc. (ADES) Delisted Director 2,099,345 $3.36 $7.05M $0 1 2015-07-02

Recent Filings

70 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 UTI Sell (S) −15,000,000 -$621.00M EDGAR
2025-12-05 UTI Buy (P) +2,735,330 $68.41M EDGAR
2025-07-29 SONO Buy (P) +6,560,435 $74.02M EDGAR
2025-03-28 UTI Sell (S) −5,000,000 -$126.75M EDGAR
2025-03-04 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Buy (P) +14,467,060 $136.93M EDGAR
2025-02-11 UTI Sell (S) −3,524,405 -$99.39M EDGAR
2025-01-14 ModivCare Inc (MODV) Delisted Buy (P) +9,014,544 $59.98M EDGAR
2024-12-03 UTI Sell (S) −12,417,895 -$311.69M EDGAR
2024-06-25 MCFT Buy (P) +537,580 $10.48M EDGAR
2024-05-17 Lazydays Holdings, Inc. (LAZY) Delisted Other (J) $0 EDGAR
Showing 110 of 70
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.